Contrive Datum Insights has published "Urinary Catheters Market Size, Share & Industry Analysis, By Product (Indwelling (Foley) Catheters, Intermittent Catheters, External Catheters, Suprapubic Catheter), Coating type (Coated Catheters, Uncoated Catheters), Material (Silicone, Latex, Silicone-Coated Latex, PVC, Other Materials), Application (Urinary Incontinence, Benign Prostate Hyperplasia (BPH), Spinal Cord Injury, Post-Surgical Urinary Retention, Neurogenic Bladder, Chronic Urinary Retention, Prostate Cancer, Other Urological Conditions), Gender (Male, Female), End use (Hospitals, Ambulatory Surgical Centers (ASCs), Clinics, Long-term Care Facilities/Nursing Homes, Home Care Settings), Distribution channel (Direct Tenders, Distributors/Wholesalers, Retail Pharmacies, Online Channels), and Regional Forecast, 2026-2034". The study sizes the global urinary catheters market at USD 6.3 billion in 2025 and projects growth from USD 6.68 billion in 2026 to USD 10.55 billion by 2034, a compound annual growth rate of 5.88% across the forecast period.
Urinary catheters are medical devices used to drain urine from the bladder when a patient cannot void naturally, ranging from single-use intermittent tubes to catheters left in place for extended periods with an external drainage bag. They are used across indwelling (Foley), intermittent, external (condom-style) and suprapubic forms, each suited to different clinical situations from short-term post-surgical drainage to long-term management of neurogenic or obstructive bladder conditions. Buyers include hospitals, ambulatory surgical centers, long-term care facilities and individual patients managing chronic conditions at home, typically under a clinician's prescription or care plan.
Rising prevalence of urinary incontinence and chronic urological conditions among aging populations
Rising prevalence of urinary incontinence and chronic urological conditions among aging populations is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 5.88% a year, the product lines exposed to it move fastest: Intermittent Catheters compounds at 8.08%, taking its share of revenue from 34% to 41% and its value from USD 2.142 billion to USD 4.326 billion.
On the upside, the study's bull case assumes the bull case assumes faster public and private reimbursement approval for intermittent self-catheterization products across Asia Pacific and Latin America, pulling adoption that would otherwise phase in later in the forecast period into earlier years, which would take 2034 revenue to USD 11.605 billion rather than the USD 10.55 billion base case.
However, the bear case assumes tighter hospital procurement budgets and slower rollout of home-care catheterization programs across Europe and North America hold volume growth below the base case through the forecast period, which would hold 2034 revenue to USD 9.284 billion. Indwelling (Foley) Catheters, which carries 42% of 2025 revenue, already grows at only 4.07% against the market's 5.88%, so the largest part of the base is also its slowest.
Key Players Compete on Indwelling (Foley) Catheters Volume and Intermittent Catheters Growth
Competition in the global urinary catheters market runs along the product axis rather than the regional one. Indwelling (Foley) Catheters holds 42% of 2025 revenue at USD 2.646 billion and remains the largest line through 2034 at 36%, making it the position hardest for a challenger to take. Intermittent Catheters, growing at 8.08%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 6.3 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product | Indwelling (Foley) Catheters | 42% · USD 2.646 billion | — |
| Coating type | Coated Catheters | 58% · USD 3.654 billion | — |
| Material | Silicone | 38% · USD 2.394 billion | — |
| Application | Urinary Incontinence | 27% · USD 1.701 billion | Chronic Urinary Retention 7.14% |
| Gender | Male | 58% · USD 3.654 billion | Female 6.17% |
| End use | Hospitals | 44% · USD 2.772 billion | Home Care Settings 8.77% |
| Distribution channel | Direct Tenders | 40% · USD 2.52 billion | Online Channels 13.05% |
- Based on regional analysis, North America led the global urinary catheters market in 2025 with 37% of global revenue at USD 2.331 billion, reaching USD 3.587 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 29% in 2034, with revenue growing from USD 1.512 billion to USD 3.06 billion.
- Middle East and Africa remains the smallest region throughout, at 6% of 2025 revenue and 6% by 2034.
- Intermittent Catheters is projected to grow at 8.08% over the forecast period, the fastest of any product line.
- The United States is the largest single country market at USD 2.051 billion in 2025, 32.56% of global revenue.
The report segments the market across seven axes; by product, and by coating type, material, application, gender, end use and distribution channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 9.284 billion and USD 11.605 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.